Clinical trial Recruiting at 1 site Interventional Ages 13 to 21 Women only

Vitamin D replacement for adolescent females with PCOS and low vitamin D

Official title: Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

Run by Yale University · NCT04355572 · Data updated 2026-11-12

This study will try daily vitamin D (4,000 IU) versus placebo in adolescent females ages 13–21 who have PCOS and low vitamin D to see if it improves hormone and metabolic blood tests over six months.

More Vitamin D Deficiency trials

Quick facts

Study typeInterventional
Ages13 Years to 21 Years
SexWomen only
Enrollment60 (estimated)
SponsorYale University
Academic / other
Locations1 site (New Haven, Connecticut)
StatusRecruiting
StartedSeptember 2026
Main results expectedAugust 31, 2028
Study endsAugust 31, 2028
Registry record updatedAugust 20, 2026
Trial IDNCT04355572 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Postmenarchal adolescent females aged 13–21 who meet modified Rotterdam criteria for PCOS and have a serum vitamin D level between 6 and 29 ng/mL, without other causes of hyperandrogenism or calcium/vitamin D metabolic disorders.

Probably not a fit

Patients with very low vitamin D (≤5 ng/mL), other causes of hyperandrogenism, chronic renal disease, or known calcium/vitamin D metabolic disorders are excluded and would not be expected to benefit from this randomized comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a double-blind, randomized, placebo-controlled trial at Yale New Haven Children's Hospital enrolling postmenarchal females (13–21) who meet modified Rotterdam criteria for PCOS and have serum vitamin D 6–29 ng/mL. Participants are randomized to 4,000 IU vitamin D daily or matching placebo and followed for six months with lab testing at baseline, 3 months, and 6 months. Key measurements include AMH, vitamin D, lipid profile, glucose and insulin, androgen testing, and female hormone testing while participants and investigators remain blinded. Patients with severe deficiency (≤5 ng/mL) or other exclusionary conditions are managed clinically rather than randomized.

Why it matters

Potential benefit: If successful, vitamin D replacement could improve ovarian hormone markers, menstrual symptoms, and metabolic risk factors in adolescents with PCOS.

How similar studies have gone: Small randomized and observational studies have reported mixed effects of vitamin D on insulin resistance and androgen levels in PCOS, so the approach is plausible but not definitively proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Postmenarchal adolescent females aged 13-21 who meet modified Rotterdam criteria for PCOS, with a serum vitamin D level between 6-29 ng/mL.

Exclusion Criteria:

* Other causes for hyperandrogenism,
* Chronic renal diseases,
* Acquired or inherited calcium and vitamin D metabolic disorders.

Where it's running

  • Yale New Haven Children's Hospital
    New Haven, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.